Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  PAREXEL International Corporation    PRXL

Delayed Quote. Delayed  - 04/29 09:59:58 pm
61.1 USD   +0.86%
04/28 PAREXEL : Kohlrausch dedication Billerica heroes of old, men of reno..
04/27 PAREXEL : meets 3Q profit forecasts
04/27 PAREXEL : Reports Third Quarter Fiscal Year 2016 Results
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo PAREXEL International Corp
Provides clinical research and development services

PAREXEL International Corp. is a biopharmaceutical services company.

It provides clinical research, medical communications, consulting, commercialization and informatics, and technology services to pharmaceutical, biotechnology, and medical device industries.

The company operates through the following segments: Clinical Research Services, PAREXEL Consulting Services and PAREXEL Informatics.

The Clinical Research Services segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, date management and biostatistics, epidemiology and health economics/outcomes research, clinical logistics, pharmacovigilance, clinical pharmacology, and related medical affiairs, patient recruitment and investigator site services.

The PAREXEL Consulting Services segment provides technical expertise and advice in drug development, regulatory affairs, and good manufacturing practice compliance consulting.

The PAREXEL Informatics segment provides information technology solutions designed to improve client's product development processes.

PAREXEL International was founded by Josef H. von Rickenbach and Anne B. Sayigh in 1983 and is headquartered in Waltham, MA.

Number of employees : 18 660 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Clinical Research Services1,45564.2%1,53565.8% +5.5%
PAREXEL Informatics267.9011.8%264.6711.3% -1.21%
PAREXEL Consulting Services216.189.5%215.959.3% -0.11%
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
The Americas970.8942.8%70.903% -92.7%
Europe, Middle East & Africa709.1431.3%451.4619.4% -36.34%
Asia/Pacific259.3311.4%269.3011.5% +3.84%
United States--984.6842.2%-
United Kingdom--239.6510.3%-
Managers
NameAgeSinceTitle
Josef H. von Rickenbach, MBA611983Chairman & Chief Executive Officer
Mark A. Goldberg, MD551997President & Chief Operating Officer
Ingo Bank, MBA472013Chief Financial Officer & Senior Vice President
Roland Andersson, PhD522014Senior Vice President-Clinical Research Services
Sy Pretorius MD, MBA--Chief Scientific Officer & Vice President
A. Dana Callow Jr., MBA641986Independent Director
Patrick J. Fortune PhD, MBA691996Independent Director
Richard L. Love722002Independent Director
Ellen M. Zane642006Independent Director
Christopher J. Lindop, CPA572006Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 53,690,271 52,735,659 98.2% 0 0.0% 98.2%
Shareholders
NameEquities%
BlackRock Fund Advisors 4,541,427 8.46%
The Vanguard Group, Inc. 4,451,424 8.29%
Wellington Management Co. LLP 2,531,349 4.71%
Fisher Asset Management LLC 2,336,981 4.35%
UBS Financial Services, Inc. 2,136,210 3.98%
Frontier Capital Management Co. LLC 2,023,123 3.77%
SSgA Funds Management, Inc. 1,720,468 3.20%
Neuberger Berman LLC 1,479,417 2.76%
Acadian Asset Management LLC 1,311,469 2.44%
Northern Trust Investments, Inc. 1,063,358 1.98%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
INCYTE CORPORATIO..
CELLTRION, INC.
LONZA GROUP AG
QUINTILES TRANSNA..
ALKERMES PLC
ALNYLAM PHARMACEU..
QIAGEN NV
SEATTLE GENETICS,..
IONIS PHARMACEUTI..
UNITED THERAPEUTI..
CHARLES RIVER LAB..
ICON PLC
ACADIA PHARMACEUT..
BIO-TECHNE CORP
PAREXEL INTERNATI..
BB BIOTECH AG
-
INTREXON CORP
ANACOR PHARMACEUT..
PRA HEALTH SCIENC..
INC RESEARCH HOLD..
Sector Biotechnology & Medical Research
PAREXEL International Corp : Connections
Ascalon International, Inc.
MedAptus, Inc.
Harvard T.H. Chan School of Public Health
Tufts University
PMed Management LLC
New England Healthcare Institute
Century Capital Management, Inc.
Syndevrx, Inc.
PAREXEL International Ltd.
Translational Accelerators LLC
Jobs for Massachusetts, Inc.
PHT Technologies, Inc.
The Leukemia & Lymphoma Society, Inc.
George Washington University
MedTrust Online LLC
Association of Clinical Research Organizations
CardioMEMS, Inc.
GlycoFi, Inc.
Applied Microarrays, Inc.
Epigenesis Pharmaceuticals LLC
Caris Molecular Profiling Institute, Inc.
Sapphire Therapeutics, Inc.
Molecular Profiling Institute, Inc.
University of Wisconsin Foundation
TVP Management Co. LLC
University of Illinois
Minuteman Health, Inc.
Cleveland Clinic
Sun Mountain Capital LLC
The Floating Hospital, Inc.
Cleveland Clinic Innovations
Press Ganey Associates, Inc.
CerRx, Inc.
Agnovos Healthcare LLC
Cancer Prevention Pharmaceuticals, Inc.
Global Med Technologies, Inc.
Company contact information
PAREXEL International Corp.
195 West Street
Waltham, MA 02451

Phone : +1.781.487.9900
Fax : +1.781.487.0525
Web : www.parexel.com
© 2016 People , Fundamentals and Ownership